1. Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma. (4th March 2022) Authors: Muhammed, Ambreen; D'Alessio, Antonio; Enica, Andrei; Talbot, Thomas; Fulgenzi, Claudia Angela Maria; Nteliopoulos, Georgios; Goldin, Robert D.; Cortellini, Alessio; Pinato, David J. Journal: Expert review of molecular diagnostics Issue: Volume 22:Number 3(2022) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. (13th January 2023) Authors: Talbot, Thomas; D'Alessio, Antonio; Pinter, Matthias; Balcar, Lorenz; Scheiner, Bernhard; Marron, Thomas U.; Jun, Tomi; Dharmapuri, Sirish; Ang, Celina; Saeed, Anwaar; Hildebrand, Hannah; Muzaffar, Mahvish; Fulgenzi, Claudia A. M.; Amara, Suneetha; Naqash, Abdul Rafeh; Gampa, Anuhya; Pillai, Anja... Journal: Liver international Issue: Volume 43:Number 3(2023) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma. (July 2021) Authors: Pinato, David J; Valeri, Nicola; Muhammed, Ambreen; Cortellini, Alessio Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 7(2021) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗